Ivarmacitinib, a novel Janus kinase 1 inhibitor, may be considered a potential treatment for patients with moderate to severe ...

Patients with early RA who did not require a biologic disease-modifying antirheumatic drug (DMARD) had a higher chance of ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

Moderate alcohol consumption and eating oily fish, fruits, and cereals may reduce the risk for rheumatoid arthritis.

Objectives To assess the effect of treatment on haemostatic parameters in patients with early rheumatoid arthritis (RA).